James Cavanaugh is listed as a director on 2 SEC Form D filings by 1 issuer between Nov 2017 and Mar 2023: LEAP THERAPEUTICS, INC. (Cambridge, MA — pharmaceuticals — 2017–2023; $77.2M reported sold to 121 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
The issuer belongs to the sponsor group Healthcare (6 issuers, $81.2M reported sold, 2010–2023).
What this means A sponsor group is one team that sets up a new company for each deal. Healthcare has 6 companies on file and $81.2M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 2 public filings for James Cavanaugh and found 5 differences: Form D filed 55 days after the first sale; Industry group changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.